| Yanine Maria Velasquez, | |
|
13800 Veterans Way, Orlando, FL 32827-7401 | |
| (407) 631-1000 | |
| Not Available |
| Full Name | Yanine Maria Velasquez |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 7 Years |
| Location | 13800 Veterans Way, Orlando, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093236515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | P06501 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Villages Regional Hospital, The | The villages, FL | Hospital |
| Uf Health Leesburg Hospital | Leesburg, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tricounty Health Llc | 0244565455 | 3 |
News Archive
Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
BioLineRx, a biopharmaceutical development company, announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) claiming the crystalline form of BL-1020, a first-in-class orally available treatment for schizophrenia.
› Verified 7 days ago
| Provider Name | Timothy C Runyon Dpm Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093869851 PECOS PAC ID: 4486568250 Enrollment ID: O20031117000143 |
News Archive
Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
BioLineRx, a biopharmaceutical development company, announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) claiming the crystalline form of BL-1020, a first-in-class orally available treatment for schizophrenia.
› Verified 7 days ago
| Provider Name | Tricounty Health Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619435179 PECOS PAC ID: 0244565455 Enrollment ID: O20190710002906 |
News Archive
Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
BioLineRx, a biopharmaceutical development company, announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) claiming the crystalline form of BL-1020, a first-in-class orally available treatment for schizophrenia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yanine Maria Velasquez, 70 Hunnewell Ave, Elmont, NY 11003-2707 Ph: (516) 244-4590 | Yanine Maria Velasquez, 13800 Veterans Way, Orlando, FL 32827-7401 Ph: (407) 631-1000 |
News Archive
Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.
A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
For people with Down syndrome, news from Elixirgen, LLC may brighten their day. The biotechnology company, located in the Science + Technology Park at Johns Hopkins, has outlined one of the best potential therapies yet for people with Down syndrome and other chromosome disorders in a paper entitled, "Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures," published in the journal DNA Research.
BioLineRx, a biopharmaceutical development company, announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office (USPTO) claiming the crystalline form of BL-1020, a first-in-class orally available treatment for schizophrenia.
› Verified 7 days ago
Amber M Shane, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 250 N Alafaya Trl, Ste 115, Orlando, FL 32828 Phone: 407-447-1020 Fax: 407-447-1239 | |
Jawad A. Malik, D.p.m., P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 710 Governors Ave, Orlando, FL 32808 Phone: 407-913-3965 | |
Total Foot And Ankle Center Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10417 Moss Park Road, Orlando, FL 32832 Phone: 407-737-2751 Fax: 407-641-8515 | |
Visiting Podiatrist Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 7647 Tern Dr, Orlando, FL 32822 Phone: 407-658-9553 | |
Dr.laurence Richman Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 810 E Colonial Dr, Orlando, FL 32803 Phone: 407-841-8050 Fax: 407-841-1631 | |
Dr. Timothy John Miller, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3701 Avalon Park West Blvd Ste 225, Orlando, FL 32828 Phone: 407-863-3655 Fax: 321-248-3763 |